Phreesia (FRA:19P) EPS without NRI: €0.13 (TTM As of Apr. 2026)


FRA:19P Phreesia Inc FRA:19P
65 GF Score
Price €9.50
GF Value €23.45
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Phreesia EPS without NRI?

Phreesia FRA:19P +2.15% 65 EPS without NRI is €0.13 as of Apr. 2026. GuruFocus rates FRA:19P with a GF Score™ of 65/100 and a GF Value™ of €23.45 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 512 Healthcare Providers & Services companies, Phreesia ranks worse than 195312.3% on this metric.

Phreesia's earnings per share without non-recurring items for the three months ended in Apr. 2026 was €0.04. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Apr. 2026 was €0.13.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Phreesia's EPS without NRI or its related term are showing as below:

During the past 9 years, Phreesia's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 69.50% per year. The lowest was -53.50% per year. And the median was 24.50% per year.

FRA:19P's 3-Year EPS without NRI Growth Rate is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 11
* Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.

Phreesia's EPS (Diluted) for the three months ended in Apr. 2026 was €0.04. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Apr. 2026 was €0.13.

Phreesia's EPS (Basic) for the three months ended in Apr. 2026 was €0.04. Its EPS (Basic) for the trailing twelve months (TTM) ended in Apr. 2026 was €0.13.


Phreesia  (FRA:19P) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Phreesia EPS without NRI Related Terms


Phreesia EPS without NRI Historical Data

* Premium members only.

The historical data trend for Phreesia's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Phreesia EPS without NRI Chart

Phreesia Annual Data
Trend Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
EPS without NRI
Get a 7-Day Free Trial Premium Member Only -2.10 -3.12 -2.29 -0.99 0.04

Phreesia Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.06 0.01 0.06 0.02 0.04

FRA:19P vs EVH, CTEV, MDRX: EPS without NRI Comparison

For the Health Information Services subindustry, Phreesia's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Phreesia PE Ratio without NRI vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Phreesia's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Phreesia's PE Ratio without NRI falls into.


FRA:19P
65GF Score
Phreesia Inc FRA:19P
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Phreesia EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of €0.13 mean?
Phreesia (FRA:19P) has a EPS without NRI of €0.13 as of Apr. 2026. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Phreesia and its competitors. According to the industry distribution chart, Phreesia ranks #999999 out of 512 companies in the Healthcare Providers & Services industry.
Is Phreesia's EPS without NRI too high?
Phreesia's current EPS without NRI is €0.13. Based on the distribution chart, Phreesia ranks #999999 out of 512 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Phreesia has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Phreesia's EPS without NRI compare to EVH and CTEV?
According to the Healthcare Providers & Services industry distribution chart, Phreesia ranks #999999 out of 512 companies for EPS without NRI. This places Phreesia in the lower half of its industry. The industry median EPS without NRI is 11.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Healthcare Providers & Services company?
The median EPS without NRI among Healthcare Providers & Services companies is 11.00, based on 512 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Phreesia and its competitors. For the Healthcare Providers & Services industry, the median EPS without NRI is 11.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Phreesia's current EPS without NRI is €0.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Phreesia stock overvalued right now?
Based on GuruFocus' analysis, Phreesia (FRA:19P) is currently considered Possible Value Trap. The stock's GF Value™ is €23.45, compared to a current price of €9.50 — trading 59.5% below its estimated fair value. The current EPS without NRI is €0.13. Phreesia's overall GF Score™ is 65/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Phreesia (FRA:19P), the current EPS without NRI is €0.13 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Phreesia (FRA:19P) Overvalued in 2026?

Based on GuruFocus' analysis, Phreesia stock appears to be undervalued. The current stock price of €9.50 is trading 59.5% below its estimated GF Value™ of €23.45. GuruFocus considers Phreesia to be Possible Value Trap.

Key valuation signals for FRA:19P:

  • EPS without NRI: €0.13
  • GF Value™: €23.45 vs. price of €9.50 (59.5% below fair value)
  • GF Score™: 65/100 with 4 warning signs

No single metric tells the full story. See the FRA:19P stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Phreesia Business Description

Other Exchanges PHR:USA
Address 1521 Concord Pike, Suite 301, PMB 221, Wilmington, DE, USA, 19803
Phreesia Inc is a provides an integrated software, payments, and engagement platform designed to address three foundational challenges in healthcare delivery: access to care, affordability of care, and patient health outcomes. Its platform is embedded directly into provider workflows and patient interactions, enabling healthcare organizations to activate patients, streamline administrative processes, and improve financial performance across the care continuum. The group serves a diverse group of healthcare organizations, including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest, and not-for-profit and other organizations.
65GF Score

Get the complete analysis for FRA:19P

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€9.50
Price
€23.45
GF Value